LFST
Lifestance Health Group Inc
11.80$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.0% | -0.2% | +0.6% | -0.5% | +0.5% | -0.6% | +2.0% | +0.1% | +2.6% | -2.6% | +1.7% | |
| – | -14.6% | +8.1% | +13.8% | +3.3% | +8.9% | -2.5% | +17.8% | +0.4% | +15.5% | -14.5% | +6.2% | |
| – | +85.0% | -37.3% | +75.9% | +18.0% | +50.6% | -13.1% | +40.6% | +7.9% | +21.9% | -21.7% | +16.0% | |
| – | +85.0% | -37.3% | +75.9% | +18.0% | +50.6% | -13.1% | +40.6% | +7.9% | +21.9% | -21.7% | +16.0% | |
| – | -16.1% | +40.0% | -5.0% | -5.4% | -16.5% | +6.3% | -7.8% | -6.5% | -20.9% | +28.4% | -9.7% | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.3% | +0.6% | |
| – | -5.4% | -5.7% | -4.1% | -2.4% | -2.3% | -1.8% | -1.8% | -1.7% | -1.7% | -1.4% | -1.3% | |
| – | -5.4% | -0.5% | +1.8% | -2.7% | +0.2% | -3.6% | +3.9% | -2.5% | +4.1% | -2.1% | +5.4% | |
| – | -15.8% | +2.3% | +9.7% | -4.5% | +5.2% | -9.4% | +16.8% | -5.7% | +10.2% | -4.9% | +14.6% | |
| – | +6.9% | +6.6% | -1.0% | -6.1% | +15.8% | -16.6% | +22.5% | +3.6% | -24.2% | +4.0% | -1.8% | |
| – | +123.2% | -48.6% | -16.5% | -27.0% | -0.5% | +2.4% | +5.1% | +56.8% | -49.9% | -29.9% | +157.5% | |
| – | +12.8% | -0.1% | -0.1% | -0.1% | +0.3% | -1.2% | -1.3% | -1.3% | -1.3% | -1.3% | -1.3% | |
| – | -1.8% | +0.0% | +0.1% | +0.5% | +0.6% | +0.7% | +1.2% | +1.3% | +1.9% | -2.9% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | +1.2% | +0.8% | +0.2% | -0.2% | +2.9% | -1.0% | +0.6% | +1.1% | +0.5% | -2.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.